Smile-Link Healthcare Global Berhad (KLSE:SMILE)
Malaysia · Delayed Price · Currency is MYR 0.0700
0.00 (0.00%)
At close: Mar 30, 2026
KLSE:SMILE Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 24.05 | 27.35 | 33.52 | 35.35 | 34.53 | 30.99 | |
Revenue Growth (YoY) | -31.97% | -18.39% | -5.18% | 2.38% | 11.40% | 17.64% |
Cost of Revenue | 11.07 | 14.39 | 21.32 | 17.32 | 15.19 | 11.94 |
Gross Profit | 12.98 | 12.96 | 12.19 | 18.03 | 19.33 | 19.05 |
Selling, General & Admin | 15.56 | 15.92 | 14.78 | 16.82 | 16.8 | 20.68 |
Other Operating Expenses | -0.63 | -1.53 | -0.34 | -0.04 | -0.03 | -0.02 |
Operating Expenses | 14.93 | 14.38 | 14.44 | 16.78 | 16.77 | 20.66 |
Operating Income | -1.96 | -1.42 | -2.24 | 1.24 | 2.56 | -1.61 |
Interest Expense | -0.69 | -0.74 | -1.31 | -1.04 | -1.02 | -0.4 |
Interest & Investment Income | 0 | 0 | 0.01 | - | 0 | 0.1 |
Currency Exchange Gain (Loss) | 0.03 | 0.03 | 0.03 | - | - | 0.02 |
Other Non Operating Income (Expenses) | -0.27 | -0.27 | - | 0 | - | - |
EBT Excluding Unusual Items | -2.88 | -2.39 | -3.51 | 0.2 | 1.54 | -1.89 |
Gain (Loss) on Sale of Assets | 2.45 | 2.45 | 0.26 | - | 0.05 | 0.06 |
Other Unusual Items | 0.11 | 0.11 | 0.37 | - | - | 0.04 |
Pretax Income | -0.32 | 0.17 | -2.89 | 0.2 | 1.59 | -1.79 |
Income Tax Expense | 0.28 | 0.33 | -0.26 | 0.06 | 0.55 | 0.04 |
Earnings From Continuing Operations | -0.6 | -0.16 | -2.63 | 0.14 | 1.04 | -1.83 |
Minority Interest in Earnings | -0.12 | -0.11 | -0.15 | -0.05 | -0.04 | -0 |
Net Income | -0.72 | -0.27 | -2.78 | 0.09 | 1 | -1.83 |
Net Income to Common | -0.72 | -0.27 | -2.78 | 0.09 | 1 | -1.83 |
Net Income Growth | - | - | - | -90.91% | - | - |
Shares Outstanding (Basic) | 252 | 252 | 250 | 250 | 250 | 250 |
Shares Outstanding (Diluted) | 252 | 252 | 250 | 351 | 250 | 250 |
Shares Change (YoY) | -28.05% | 0.73% | -28.57% | 39.99% | 0.01% | - |
EPS (Basic) | -0.00 | -0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
EPS (Diluted) | -0.00 | -0.00 | -0.01 | 0.00 | 0.00 | -0.01 |
EPS Growth | - | - | - | -93.52% | - | - |
Free Cash Flow | 3.3 | 4.06 | 3.43 | 0.03 | -0.29 | 4.98 |
Free Cash Flow Per Share | 0.01 | 0.02 | 0.01 | - | -0.00 | 0.02 |
Dividend Per Share | - | - | - | - | 0.001 | 0.002 |
Dividend Growth | - | - | - | - | -50.00% | 33.33% |
Gross Margin | 53.97% | 47.39% | 36.39% | 50.99% | 56.00% | 61.47% |
Operating Margin | -8.13% | -5.19% | -6.69% | 3.51% | 7.42% | -5.20% |
Profit Margin | -3.02% | -0.97% | -8.29% | 0.26% | 2.90% | -5.91% |
Free Cash Flow Margin | 13.73% | 14.86% | 10.23% | 0.09% | -0.83% | 16.08% |
EBITDA | -0.57 | 0.42 | 0.04 | 3.37 | 5.6 | 1.09 |
EBITDA Margin | -2.36% | 1.53% | 0.11% | 9.54% | 16.21% | 3.52% |
D&A For EBITDA | 1.39 | 1.84 | 2.28 | 2.13 | 3.03 | 2.7 |
EBIT | -1.96 | -1.42 | -2.24 | 1.24 | 2.56 | -1.61 |
EBIT Margin | -8.13% | -5.19% | -6.69% | 3.51% | 7.42% | -5.20% |
Effective Tax Rate | - | 191.76% | - | 31.68% | 34.76% | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.